Denali Therapeutics Inc.
Long

DNLI a long-term add over 53.50

This is not a commentary on the promising fundamentals or potential of Denali Therapeutics but rather a purely technical analysis. DNLI has been consolidating in a falling wedge pattern coming off a nice run up from August of 2020. Price seems to have found a recent bottom at the all-time 50% fib as well a s the 200ema. These are critical levels to hold but so long as it does a bounce out of this wedge pattern seems likely.

Disclaimer